Mild chronic obstructive pulmonary disease: why spirometry is not sufficient! (Q39332602)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

Mild chronic obstructive pulmonary disease: why spirometry is not sufficient! (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

21 March 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Grace Parraga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Katherine A Webb

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

J Alberto Neder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Denis E O'Donnell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Canadian Respiratory Research Network (CRRN)

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

publication date

5 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Respiratory Medicine

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

549-563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

Pathogenesis of chronic obstructive pulmonary disease

21 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Do GOLD stages of COPD severity really correspond to differences in health status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Gender bias in the diagnosis of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Under-diagnosis of chronic obstructive pulmonary disease: a qualitative study in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Spirometry use among older adults with chronic obstructive pulmonary disease: 1999-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

"GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study".

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Determinants of spirometry use and accuracy of COPD diagnosis in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Resting Physiological Correlates of Reduced Exercise Capacity in Smokers with Mild Airway Obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Estimating population prevalence of potential airflow obstruction using different spirometric criteria: a pooled cross-sectional analysis of persons aged 40-95 years in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Global and regional estimates of COPD prevalence: Systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Prioritised research agenda for prevention and control of chronic respiratory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Mechanisms of exercise intolerance in global initiative for chronic obstructive lung disease grade 1 COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Physiologic characterization of the chronic bronchitis phenotype in GOLD grade IB COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Prevalence of airflow obstruction in smokers and never-smokers in Switzerland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Asymptomatic subjects with airway obstruction have significant impairment at exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Site and Nature of Airway Obstruction in Chronic Obstructive Lung Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

21 January 2018

The Lung's Quiet Zone

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Small-airway obstruction and emphysema in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Measuring Airway Remodeling in Patients With Different COPD Staging Using Endobronchial Optical Coherence Tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Contributions of Loss of Lung Recoil and of Enhanced Airways Collapsibility to the Airflow Obstruction of Chronic Bronchitis and Emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Orthopnea and tidal expiratory flow limitation in patients with stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Mechanisms of exertional dyspnoea in symptomatic smokers without COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Early Detection of Airways Obstruction by the Closing Volume Technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Impulse oscillometry: interpretation and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Changes in forced expiratory volume in 1 second over time in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Quantitative CT assessment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Persistence of circulating endothelial microparticles in COPD despite smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Haemodynamic responses to exercise in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Pulmonary hemodynamic profile in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Pulmonary vascular involvement in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Pulmonary hypertension in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Physical activity in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Clinical and Radiologic Disease in Smokers With Normal Spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Impact of emphysema and airway wall thickness on quality of life in smoking-related COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Validity of apparent diffusion coefficient hyperpolarized 3He-MRI using MSCT and pulmonary function tests as references.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Ventilation Heterogeneity in Never-smokers and COPD:: Comparison of Pulmonary Functional Magnetic Resonance Imaging with the Poorly Communicating Fraction Derived From Plethysmography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

COPD: Do Imaging Measurements of Emphysema and Airway Disease Explain Symptoms and Exercise Capacity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Capability of differentiating smokers with normal pulmonary function from COPD patients: a comparison of CT pulmonary volume analysis and MR perfusion imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Dynamic contrast enhanced magnetic resonance perfusion imaging in high-risk smokers and smoking-related COPD: correlations with pulmonary function tests and quantitative computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Exercise ventilatory inefficiency in mild to end-stage COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Sub-clinical left and right ventricular dysfunction in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Early changes of cardiac structure and function in COPD patients with mild hypoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

The prevalence of quadriceps weakness in COPD and the relationship with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Ventilatory limitations in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Exercise limitation in chronic obstructive pulmonary disease. The O'Donnell threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Diaphragm electromyography using an oesophageal catheter: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Peripheral muscle alterations in non-COPD smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Skeletal muscle capillarization and oxidative metabolism in healthy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Comparison of gas exchange, lactate, and lactic acidosis thresholds in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Percent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle Studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Percent emphysema, airflow obstruction, and impaired left ventricular filling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

21 January 2018

Comorbidities of COPD

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Mortality in COPD: Role of comorbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Airflow limitation in smokers is associated with subclinical atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

COPD as a systemic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Skeletal muscle inflammation and nitric oxide in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Diaphragm dysfunction in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Peripheral muscle dysfunction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Loss of bone density with inhaled triamcinolone in Lung Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Comprehensive pulmonary rehabilitation according to severity of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Pulmonary rehabilitation for mild COPD: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Roflumilast: a review of its use in the treatment of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

Effects of cigarette smoke and hypoxia on pulmonary circulation in the guinea pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1334553

10.1080/17476348.2017.1334553

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28548545%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference